Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

• Status: Recruiting
• Trial end date: 2029-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: ECOG-ACRIN Cancer Research Group
• Collaborator: National Cancer Institute (NCI)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• STAFF ELIGIBILITY CRITERIA:

• Must be English speaking.

• Must be employed at NCI Community Oncology Research Program (NCORP) site for at least three months.

• PATIENT ELIGIBILITY CRITERIA STEP 0:

• Patient presenting with any type of cancer with a date of diagnosis within the past 4 months. Recurrence, diagnosed within the last 4 months, of tumors in patients with past cancer diagnoses will be considered eligible. Patients with a new primary cancer, diagnosed within the last 4 months, who have been treated previously for other types of cancer will also be considered eligible. ?In situ? cancers, diagnosed within the past 4 months, will also be considered eligible.

• Patient must be a current smoker. Current smoker is defined as any cigarette smoking (even a puff) in the past 30 days.

• Patient must be fluent in both, written and spoken, English or both, written and spoken, Spanish.

• Patient must have telephone, web and e-mail access.

• NOTE: The restriction to those with web and e-mail access is based on the primary intention of the study; to assess the implementation of the virtual intervention in the NCORP network.

• ELIGIBILITY CRITERIA STEP 1: Patient must still meet all criteria outlined in step 0.

• ELIGIBILITY STEP 2 (RANDOMIZATION): Patient must have completed baseline survey in Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group Systems for Easy Entry of Patient Reported Outcomes (EASEEPRO) within 1 month (30 days) of the date of informed consent (Step 1).

Exclusion Criteria:

• Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 3 or above, or is deemed medically unable to participate by study investigators or oncology clinician (i.e., referral to hospice).

• Patient has no intention to receive their cancer care or monitoring at an NCORP community cancer site.